Strs Ohio Sells 579,993 Shares of Avantor, Inc. $AVTR

Strs Ohio cut its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 97.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,797 shares of the company’s stock after selling 579,993 shares during the period. Strs Ohio’s holdings in Avantor were worth $197,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Covestor Ltd lifted its holdings in Avantor by 120.3% during the third quarter. Covestor Ltd now owns 13,026 shares of the company’s stock worth $162,000 after acquiring an additional 7,113 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Avantor by 11.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 19,534 shares of the company’s stock worth $263,000 after purchasing an additional 2,058 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Avantor by 28.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 7,502,086 shares of the company’s stock worth $93,626,000 after buying an additional 1,640,120 shares in the last quarter. Bfsg LLC boosted its position in Avantor by 21.5% during the third quarter. Bfsg LLC now owns 13,274 shares of the company’s stock valued at $166,000 after purchasing an additional 2,349 shares during the last quarter. Finally, Evergreen Capital Management LLC grew its stake in shares of Avantor by 7.7% in the third quarter. Evergreen Capital Management LLC now owns 14,347 shares of the company’s stock valued at $179,000 after buying an additional 1,026 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Sanjeev K. Mehra acquired 350,000 shares of the company’s stock in a transaction that occurred on Friday, December 5th. The stock was acquired at an average price of $11.09 per share, with a total value of $3,881,500.00. Following the purchase, the director directly owned 350,000 shares in the company, valued at approximately $3,881,500. This trade represents a ? increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AVTR. Jefferies Financial Group cut Avantor to an “underperform” rating in a report on Wednesday, December 17th. Robert W. Baird lifted their target price on Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. UBS Group set a $12.00 price target on Avantor in a research note on Thursday, October 30th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $12.00 price objective (down from $14.00) on shares of Avantor in a research report on Thursday, October 30th. Finally, TD Cowen decreased their price objective on shares of Avantor from $14.00 to $12.00 and set a “hold” rating on the stock in a report on Wednesday, January 7th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $13.60.

Avantor Price Performance

Avantor stock opened at $11.08 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.96 and a current ratio of 1.49. Avantor, Inc. has a 52 week low of $10.62 and a 52 week high of $22.44. The stock has a market capitalization of $7.55 billion, a P/E ratio of -85.19, a price-to-earnings-growth ratio of 3.78 and a beta of 0.94. The stock has a fifty day moving average of $11.57 and a 200-day moving average of $12.39.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.